Investor · Cambridge, MA

Nancy Simonian

Open Nancy in the network graph →

Filings

17

SEC Form D

Connections

165

co-filers

Capital

$21.4M

across filings

Active

Feb 2017

to Apr 2021

Most-connected co-filers (165)

Srinivas Akkaraju · SOUTH SAN FRANCISCO, CA13 shared David A. Roth · Cambridge, MA11 shared Richard Young · CAMBRIDGE, MA10 shared Marsha A. Fanucci · Cambridge, MA7 shared Eric A. Olson · Cambridge, MA7 shared Peter E. Wirth · Cambridge, MA6 shared Robert T. Nelsen · Chicago, IL5 shared Jonathan D. Scanlon · ARLINGTON, VA4 shared Sanj A. Patel · Cambridge, MA4 shared Philip Sharp · Cambridge, MA4 shared Brooks Gibbins · NEW YORK, NY4 shared Robert Thompson · New York, NY4 shared Blake G. Modersitzki · Salt Lake City, UT4 shared Jeremy Bennett · Sioux City, IA3 shared Neil Evans · Sioux City, IA3 shared Matthew Norton · CHICAGO, IL3 shared ICQ Management, LLC · San Francisco, CA3 shared Grant Fisher · New York, NY3 shared Jeremy A. Springhorn · Cambridge, MA3 shared Ted Mills · Plymouth, MI3 shared Gerald A. Quirk · Cambridge, MA3 shared Vahe A. Dombalagian · CHICAGO, IL3 shared Dan B. Jacobi · Durham, NC3 shared Roger Newton · Plymouth, MI3 shared

Recent filings (17)

Syros Pharmaceuticals, Inc.Sep 2022 · 38 co-filers$129.8M Underline Infrastructure Inc.Aug 2022 · 11 co-filers$9.0M Underline Infrastructure Inc.Mar 2022 · 11 co-filers$9.7M MDCP Co-Investors (Patriot IV), L.P.Apr 2021 · 47 co-filers$20.6M MDCP Co-Investors (Patriot III), L.P.Apr 2021 · 47 co-filers$62.0M Syros Pharmaceuticals, Inc.Dec 2020 · 36 co-filers$121.6M Life Boost Inc.Sep 2020 · 14 co-filers$15.8M Underline Infrastructure Inc.May 2020 · 8 co-filers$2.5M Life Boost Inc.Apr 2020 · 14 co-filers$1.5M Life Boost Inc.Dec 2019 · 14 co-filers$2.0M NRFTA, Inc.Dec 2019 · 8 co-filers$3.7M Syros Pharmaceuticals, Inc.Feb 2018 · 41 co-filers$11.4M Syros Pharmaceuticals, Inc.Jan 2018 · 41 co-filers$10.0M Treligga plc - Ardevora Global Equity FundMar 2017 · 15 co-filers NFP Ultimate Holdings, LLCMar 2017 · 22 co-filers$784.2M Treligga plc - Ardevora Global Long-Only Equity FundFeb 2017 · 15 co-filers Syros Pharmaceuticals, Inc.Oct 2014 · 20 co-filers$53.1M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Nancy in the interactive graph →